Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
- PMID: 20637863
- PMCID: PMC5052066
- DOI: 10.1016/j.bbadis.2010.07.006
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
Abstract
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by multi-focal demyelination, axonal loss, and immune cell infiltration. Numerous immune mediators are detected within MS lesions, including CD4(+) and CD8(+) T lymphocytes suggesting that they participate in the related pathogenesis. Although CD4(+) T lymphocytes are traditionally considered the main actors in MS immunopathology, multiple lines of evidence suggest that CD8(+) T lymphocytes are also implicated in the pathogenesis. In this review, we outline the recent literature pertaining to the potential roles of CD8(+) T lymphocytes both in MS and its animal models. The CD8(+) T lymphocytes detected in MS lesions demonstrate characteristics of activated and clonally expanded cells supporting the notion that these cells actively contribute to the observed injury. Moreover, several experimental in vivo models mediated by CD8(+) T lymphocytes recapitulate important features of the human disease. Whether the CD8(+) T cells can induce or aggravate tissue destruction in the CNS needs to be fully explored. Strengthening our understanding of the pathogenic potential of CD8(+) T cells in MS should provide promising new avenues for the treatment of this disabling inflammatory disease.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.Am J Pathol. 2009 Sep;175(3):1160-6. doi: 10.2353/ajpath.2009.090340. Epub 2009 Aug 21. Am J Pathol. 2009. PMID: 19700745 Free PMC article.
-
Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage.J Neurosci. 2015 Mar 25;35(12):4837-50. doi: 10.1523/JNEUROSCI.3380-14.2015. J Neurosci. 2015. PMID: 25810515 Free PMC article.
-
The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.J Immunol. 2013 May 15;190(10):4991-9. doi: 10.4049/jimmunol.1300083. Epub 2013 Apr 5. J Immunol. 2013. PMID: 23562810 Free PMC article.
-
Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination.Semin Immunopathol. 2010 Jun;32(2):197-209. doi: 10.1007/s00281-010-0199-7. Epub 2010 Mar 18. Semin Immunopathol. 2010. PMID: 20237782 Review.
-
Multiple Sclerosis and T Lymphocytes: An Entangled Story.J Neuroimmune Pharmacol. 2015 Dec;10(4):528-46. doi: 10.1007/s11481-015-9614-0. Epub 2015 May 7. J Neuroimmune Pharmacol. 2015. PMID: 25946987 Free PMC article. Review.
Cited by
-
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells.Nat Immunol. 2013 Mar;14(3):254-61. doi: 10.1038/ni.2513. Epub 2013 Jan 6. Nat Immunol. 2013. PMID: 23291597 Free PMC article.
-
Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro.Eur J Immunol. 2016 Sep;46(9):2187-203. doi: 10.1002/eji.201546251. Epub 2016 Jul 22. Eur J Immunol. 2016. PMID: 27338806 Free PMC article.
-
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.BMC Neurol. 2015 Nov 11;15:232. doi: 10.1186/s12883-015-0488-9. BMC Neurol. 2015. PMID: 26559139 Free PMC article. Clinical Trial.
-
Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases.Cell Commun Signal. 2024 Feb 17;22(1):132. doi: 10.1186/s12964-024-01509-w. Cell Commun Signal. 2024. PMID: 38368403 Free PMC article. Review.
-
Multiple sclerosis: Immunopathological heterogeneity and its implications.Eur J Immunol. 2022 Jun;52(6):869-881. doi: 10.1002/eji.202149757. Epub 2022 May 6. Eur J Immunol. 2022. PMID: 35476319 Free PMC article. Review.
References
-
- Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747. - PubMed
-
- McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol. 2007;8:913–919. - PubMed
-
- Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol. 2007;7:904–912. - PubMed
-
- Llewellyn-Smith N, Lai M, Miller DH, Rudge P, Thompson AJ, Cuzner ML. Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: a study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412. Neurology. 1997;48:810–816. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials